The COVID-19 pandemic has brought not only a healthcare crisis, but also one of the worst economic downturns in history. As businesses emerge from this crisis, there may be increased risk that employees may cross the line and engage in anticompetitive conduct. Therefore, it is critical that companies and individuals prepare now to ensure that
Latest Post
More Posts
FTC Continues To Zero In On Problematic M&A Noncompetes
Third Circuit: “Rigorous Analysis” Required for Class Certification in Antitrust Cases
Bad Faith Required to Prevent Speech Regarding Potential Patent Infringement
Anticompetitive Conduct in Biologics – An Enforcement Priority with FTC and FDA
Anticompetitive Conduct in Biologics – An Enforcement Priority with FTC and FDA
Subscribe: Subscribe via RSS